SFAM

Springhill Fund Asset Management Portfolio holdings

AUM $20.9M
This Quarter Return
+96.95%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$61.6M
AUM Growth
–
Cap. Flow
+$61.6M
Cap. Flow %
100%
Top 10 Hldgs %
78.7%
Holding
17
New
17
Increased
–
Reduced
–
Closed
–

Top Buys

1
VRNA
Verona Pharma
VRNA
$6.29M
2
LEGN icon
Legend Biotech
LEGN
$6.21M
3
CYTK icon
Cytokinetics
CYTK
$6.15M
4
AZN icon
AstraZeneca
AZN
$5.01M
5
INSM icon
Insmed
INSM
$4.8M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VRNA
1
Verona Pharma
VRNA
$9.16B
$6.29M 10.22%
+135,452
New +$6.29M
LEGN icon
2
Legend Biotech
LEGN
$6.41B
$6.21M 10.08%
+190,800
New +$6.21M
CYTK icon
3
Cytokinetics
CYTK
$4.23B
$6.15M 9.99%
+130,735
New +$6.15M
AZN icon
4
AstraZeneca
AZN
$248B
$5.01M 8.14%
+76,500
New +$5.01M
INSM icon
5
Insmed
INSM
$28.8B
$4.8M 7.79%
+69,500
New +$4.8M
VERA icon
6
Vera Therapeutics
VERA
$1.38B
$4.63M 7.51%
+109,400
New +$4.63M
COGT icon
7
Cogent Biosciences
COGT
$1.69B
$4.28M 6.95%
+548,554
New +$4.28M
AKRO icon
8
Akero Therapeutics
AKRO
$3.74B
$4.21M 6.83%
+151,200
New +$4.21M
MRUS icon
9
Merus
MRUS
$4.98B
$3.52M 5.72%
+83,800
New +$3.52M
CGEM icon
10
Cullinan Oncology
CGEM
$445M
$3.37M 5.47%
+276,400
New +$3.37M
DYN icon
11
Dyne Therapeutics
DYN
$1.92B
$3.09M 5.02%
+131,200
New +$3.09M
NRIX icon
12
Nurix Therapeutics
NRIX
$714M
$3.02M 4.91%
+160,500
New +$3.02M
DRUG
13
Bright Minds Biosciences
DRUG
$276M
$2.18M 3.55%
+60,648
New +$2.18M
BCYC
14
Bicycle Therapeutics
BCYC
$511M
$1.63M 2.65%
+116,400
New +$1.63M
JANX icon
15
Janux Therapeutics
JANX
$1.37B
$1.58M 2.57%
+29,600
New +$1.58M
ABVX
16
Abivax
ABVX
$6.12B
$1.52M 2.47%
+207,600
New +$1.52M
SLNO icon
17
Soleno Therapeutics
SLNO
$3.6B
$80.6K 0.13%
+1,793
New +$80.6K